Compare Nokia Corp (NOK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs GeneDx Holdings Corp — how do they compare? Nokia Corp trades at $10.95 (market cap $56.70B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Nokia Corp is far larger — about 31.5× GeneDx Holdings Corp's market cap, and Nokia Corp pays a 1.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| NOK | WGS | |
|---|---|---|
Market Cap | $56.70B | $1.80B |
Sector | Technology | Technology |
52-Week High | $16.83 | $167.51 |
52-Week Low | $4.05 | $34.51 |
Enterprise Value | $53.51B | $1.80B |
Dividend Yield | 1.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
